Publications: Ms Caitlin Fierheller

Sun L, Wei X, Fierheller CT, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al. ( 2024 ) . Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada . JAMA Network Open vol. 7 , ( 9 )

Manchanda R ( 2024 ) . Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis . Cancers

Manchanda R, Sun L, Wei X, legood R ( 2024 ) . Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer . Journal of the National Comprehensive Cancer Network : JNCCN

Oxley S, Manchanda R ( 2024 ) . BRCA awareness and testing experience in the UK Jewish population: a qualitative study . Journal of Medical Genetics

Oxley S, Manchanda R ( 2024 ) . Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D . Cancers

Sideris M, Brincat MR, Blyuss O, Enumula M, Cyclewala S, Oxley S, Sia J, Kalra A et al. ( 2024 ) . 1033 Validation of P-POSSUM scale in ovarian cancer (OC) cytoreductive surgery . Conference: Poster and E-Postersa391.3 - a3a392 .

Gootzen TA, Kalra A, Sarig K, Sobocan M, Oxley S, Dworschak N, Georgiannakis A, Glynou S et al. ( 2024 ) . 405 Analysis of BRCA1 and BRCA2 information provision online . Conference: Poster and E-Postersa448 - a449 .

Sun L, Wei X, Fierheller CT, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al. ( 2024 ) . 406 Population-based BRCA1 and BRCA2 testing in Canada: an economic evaluation . Conference: Young Investigator Sessiona52 - a53 .

Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J, Sideris M et al. ( 2024 ) . 443 Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer . Conference: Oral Sessionsa40 - a41 .

Kalra A, Gootzen TA, Fierheller CT, Sarig K, Pan Y, Parmar A, Papalois K-B, Samuels AJ et al. ( 2024 ) . 461 HBOC and lynch syndrome: ai-powered multi-platform analysis of social media activity . Conference: Poster and E-Postersa259.1 - a2a259 .

Oxley S, Sia J, Samuels A, Kalra A, Wei X, Fierheller CT, Sideris M, Glenn Mccluggage W et al. ( 2024 ) . 583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study . Conference: Poster and E-Postersa454.1 - a4a454 .

Oxley S, Wei X, Sideris M, Blyuss O, Kalra A, Sia J, Ganesan S, Fierheller CT et al. ( 2024 ) . 948 EQ-5D utility scores for risk-reducing mastectomy and risk-reducing salpingo-oophorectomy: mapping from SF-12 and SF-36 . Conference: Poster and E-Postersa460.1 - a4a460 .

Wei X, Sun L, Slade E, Fierheller CT, Oxley S, Kalra A, Sia J, Sideris M et al. ( 2024 ) . Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer . JAMA Network Open vol. 7 , ( 2 )

Wei X, Sun L, Slade E, Oxley S, Kalra A, Sia J, Sideris M, Fierheller C et al. ( 2023 ) . EE675 Cost-Effectiveness Analysis of Cancer Susceptibility Gene-Specific Prevention and Surveillance Strategies for Ovarian and Breast Cancer . Value in Health . vol. 26 , s183 - s184 .

Sobocan M, Chandrasekaran D, Sideris M, Blyuss O, Fierheller C, Kalra A, Sia J, Miller RE et al. ( 2023 ) . Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study . BJOG An International Journal of Obstetrics & Gynaecology vol. 131 , ( 6 ) 848 - 857 .

Alenezi WM, Fierheller CT, Serruya C, Revil T, Oros KK, Subramanian DN, Bruce J, Spiegelman D et al. ( 2023 ) . Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases . Frontiers in Oncology vol. 13 ,

Fierheller CT, Alenezi WM, Serruya C, Revil T, Amuzu S, Bedard K, Subramanian DN, Fewings E et al. ( 2023 ) . Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene . Genes vol. 14 , ( 2 )

Alenezi WM, Milano L, Fierheller CT, Serruya C, Revil T, Oros KK, Behl S, Arcand SL et al. ( 2022 ) . The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population . Cancers vol. 14 , ( 9 )

Alenezi WM, Fierheller CT, Revil T, Serruya C, Mes-Masson A-M, Foulkes WD, Provencher D, Haffaf ZE et al. ( 2022 ) . Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants . Genes vol. 13 , ( 4 )

Fierheller CT, Guitton-Sert L, Alenezi WM, Revil T, Oros KK, Gao Y, Bedard K, Arcand SL et al. ( 2021 ) . A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene . Genome Medicine vol. 13 , ( 1 )

Fierheller CT, Alenezi WM, Tonin PN ( 2021 ) . The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families . Cancers vol. 13 , ( 14 )

Alenezi WM, Fierheller CT, Recio N, Tonin PN ( 2020 ) . Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers . Genes vol. 11 , ( 8 )